1032 Strong association between pathological response to neoadjuvant chemotherapy, TILs and modeled CA125 KELIM in ovarian carcinomas: CHIVA trial, GINECO

J Pierre-Alexandre; S Moret; O Colomban; P Combe; S Abadie-Lacourtoisie; J Meunier; A Floquet; L Venat-Bouvet; C Louvet; L Favier; P Follana; JP Lotz; F Del Piano; M Leheurteur; CR Alliot; G De Rauglaudre; N Raban; A Chevalier-Place; A Leary; B You

doi:10.1136/ijgc-2021-ESGO.601

Article info

Translational research biomarkers

1032 Strong association between pathological response to neoadjuvant chemotherapy, TILs and modeled CA125 KELIM in ovarian carcinomas: CHIVA trial, GINECO

Free

Authors

J Pierre-Alexandre Université de Paris, Faculté de médecine, Paris, France APHP. Centre, Hopital Cochin, Pathology department, Paris, France GINECO, Paris, France GINEGEPS, Paris, France PubMed articles Google scholar articles
S Moret Université de Paris, Faculté de médecine, Paris, France APHP. Centre, Hopital Cochin, Pathology department, Paris, France PubMed articles Google scholar articles
O Colomban Université Claude Bernard Lyon 1, EA 3738 CICLY, Lyon, France PubMed articles Google scholar articles
P Combe GINECO, Paris, France APHP. Centre, Hopital européen Georges Pompidou, Medical Oncology, Paris, France PubMed articles Google scholar articles
S Abadie-Lacourtoisie GINECO, Paris, France Institut de Cancérologie de l’Ouest – ICO – Site Paul Papin, Medical oncology, Angers, France PubMed articles Google scholar articles
J Meunier GINECO, Paris, France Centre Hospitalier Régional d’Orléans, Medical oncology, Orléans, France PubMed articles Google scholar articles
A Floquet GINECO, Paris, France Institut Bergonié, Oncology, Bordeaux, France PubMed articles Google scholar articles
L Venat-Bouvet GINECO, Paris, France Centre Hospitalier Universitaire Dupuytren, Medical oncology, Limoges, France PubMed articles Google scholar articles
C Louvet GINECO, Paris, France Institut Mutualiste Montsouris, Medical oncology, Paris, France PubMed articles Google scholar articles
L Favier GINECO, Paris, France Centre Georges François Leclerc, Medical oncology, Dijon, France PubMed articles Google scholar articles
P Follana GINECO, Paris, France Centre Antoine Lacassagne, Onco-hematology, Nice, France PubMed articles Google scholar articles
JP Lotz GINECO, Paris, France APHP. Sorbonne Université, Hopital Tenon, Medical oncology, Paris, France PubMed articles Google scholar articles
F Del Piano GINECO, Paris, France Hôpitaux du Léman, Surgery, Thonon-les-Bains, France PubMed articles Google scholar articles
M Leheurteur GINECO, Paris, France Centre Henri Becquerel, Medical oncology, Rouen, France PubMed articles Google scholar articles
CR Alliot GINECO, Paris, France Centre Hospitalier Alpes Leman, Oncology, Contamine-sur-Arve, France PubMed articles Google scholar articles
G De Rauglaudre GINECO, Paris, France Institut Sainte-Catherine, Clinical cancerology, Avignon, France PubMed articles Google scholar articles
N Raban GINECO, Paris, France CHU de Poitiers – Pôle Régional de Cancérologie – Hôpital de la Milétrie, Oncology, Poitiers, France PubMed articles Google scholar articles
A Chevalier-Place GINECO, Paris, France Centre Oscar Lambret, Gynecology, Lille, France PubMed articles Google scholar articles
A Leary GINECO, Paris, France GINEGEPS, Paris, France Gustave Roussy, Medical oncology, Villejuif, France PubMed articles Google scholar articles
B You GINECO, Paris, France GINEGEPS, Paris, France Université Claude Bernard Lyon 1, EA 3738 CICLY, Lyon, France Institut de cancérologie des Hospice Civils de Lyon IC-HCL, Medical oncology, CITOHL, Pierre-Bénite, France PubMed articles Google scholar articles

Citation

Pierre-Alexandre J, Moret S, Colomban O, et al

1032 Strong association between pathological response to neoadjuvant chemotherapy, TILs and modeled CA125 KELIM in ovarian carcinomas: CHIVA trial, GINECO

International Journal of Gynecologic Cancer 2021;31:A340.

Publication history

First published October 12, 2021.

Online issue publication

January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password